Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 1, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Mar 26, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for...
-
Feb 17, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2009. Fiscal 2009 Summary -------------------...
-
Feb 5, 2010
- Fourth quarter and year end financial results to be released February 17, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 5 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will...
-
Jan 4, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced a final judgment (the "Cipher Judgment") has been entered in favour of Cipher in relation to pending patent litigation with Purdue Pharma...